For: | Zhang JX, Wu HS, Wang H, Zhang JH, Wang Y, Zheng QC. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005; 11(28): 4423-4426 [PMID: 16038046 DOI: 10.3748/wjg.v11.i28.4423] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i28/4423.htm |
Number | Citing Articles |
1 |
Julia Lichtnekert, Volker Vielhauer, Daniel Zecher, Onkar P. Kulkarni, Sebastian Clauss, Stephan Segerer, Veit Hornung, Tanya N. Mayadas, Bruce Beutler, Shizuo Akira, Hans-Joachim Anders. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. American Journal of Physiology-Renal Physiology 2009; 296(4): F867 doi: 10.1152/ajprenal.90213.2008
|
2 |
Christopher Y. Lu. Seldin and Giebisch's The Kidney. 2013; : 2985 doi: 10.1016/B978-0-12-381462-3.00088-4
|
3 |
John R. Klune, Allan Tsung. Molecular Biology of Liver Ischemia/Reperfusion Injury: Established Mechanisms and Recent Advancements. Surgical Clinics of North America 2010; 90(4): 665 doi: 10.1016/j.suc.2010.04.003
|
4 |
Fatma Emel Kocak, Aysegul Kucuk, Filiz Ozyigit, Murat Tosun, Cengiz Kocak, Ahmet Kocak, Mehmet Fatih Ekici, Faik Yaylak, Osman Genc. Protective effects of simvastatin administered in the experimental hepatic ischemia-reperfusion injury rat model. Journal of Surgical Research 2015; 199(2): 393 doi: 10.1016/j.jss.2015.06.009
|
5 |
Pedro Pimentel-Nunes, João Bruno Soares, Roberto Roncon-Albuquerque Jr, Mário Dinis-Ribeiro, Adelino F Leite-Moreira. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opinion on Therapeutic Targets 2010; 14(4): 347 doi: 10.1517/14728221003642027
|
6 |
Florian Jürgen Raimann, Stefan Dröse, Erik Bonke, Lea Schneider, Elisabeth Tybl, Ilka Wittig, Juliana Heidler, Heinrich Heide, Ivana Josipovic, Matthias Leisegang, Ralf Peter Brandes, Jochen Roeper, Kai Zacharowski, Jan Mersmann. TLR2-Dependent Reversible Oxidation of Connexin 43 at Cys260 Modifies Electrical Coupling After Experimental Myocardial Ischemia/Reperfusion. Journal of Cardiovascular Translational Research 2019; 12(5): 478 doi: 10.1007/s12265-019-09887-0
|
7 |
Wei Wang, Li Sun, Yonghao Deng, Jie Tang. Synergistic effects of antibodies against high‐mobility group box 1 and tumor necrosis factor‐α antibodies on d‐(+)‐galactosamine hydrochloride/lipopolysaccharide‐induced acute liver failure. The FEBS Journal 2013; 280(6): 1409 doi: 10.1111/febs.12132
|
8 |
Chao Hu, Shiqiang Shen, Aimin Zhang, Bo Ren, Fusheng Lin. The liver protective effect of methylprednisolone on a new experimental acute-on-chronic liver failure model in rats. Digestive and Liver Disease 2014; 46(10): 928 doi: 10.1016/j.dld.2014.06.008
|
9 |
Fang Hua, Jing Ma, Tuanzhu Ha, Jim L. Kelley, Race L. Kao, John B. Schweitzer, John H. Kalbfleisch, David L. Williams, Chuanfu Li. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Research 2009; 1262: 100 doi: 10.1016/j.brainres.2009.01.018
|
10 |
Yao Tong, Zhuang Yu, Renlingzi Zhang, Xibing Ding, Zhixia Chen, Quan Li. WISP1 mediates lung injury following hepatic ischemia reperfusion dependent on TLR4 in mice. BMC Pulmonary Medicine 2018; 18(1) doi: 10.1186/s12890-018-0744-z
|
11 |
Jan Mersmann, Nguyen Tran, Kathrina Latsch, Katharina Habeck, Franziska Iskandar, René Zimmermann, Kai Zacharowski. Akt or phosphoinositide-3-kinase inhibition reverses cardio-protection in Toll-like receptor 2 deficient mice. Resuscitation 2012; 83(11): 1404 doi: 10.1016/j.resuscitation.2012.04.001
|
12 |
Athanasios Katsargyris, Chris Klonaris, Andreas Alexandrou, Alexander E Giakoustidis, Ioanna Vasileiou, Stamatios Theocharis. Toll like receptors in liver ischemia reperfusion injury: A novel target for therapeutic modulation?. Expert Opinion on Therapeutic Targets 2009; 13(4): 427 doi: 10.1517/14728220902794939
|
13 |
Jessica Howell, Paul Gow, Peter Angus, Kumar Visvanathan. Role of toll-like receptors in liver transplantation. Liver Transplantation 2014; 20(3): 270 doi: 10.1002/lt.23793
|
14 |
Andrew J Vardanian, Jerzy W Kupiec-Weglinski. Organ preservation injury and innate immunity. Current Opinion in Organ Transplantation 2007; 12(2): 135 doi: 10.1097/MOT.0b013e328091c1c2
|
15 |
Christopher Y. Lu, Martin Senitko. Seldin and Giebisch's The Kidney. 2008; : 2577 doi: 10.1016/B978-012088488-9.50093-0
|
16 |
Hossein-Ali Arab, Kee Cheung, Peter E. Hickman, Julia M. Potter, Neal I. Walker, Michael S. Roberts. A comparison of hepatic ischemia/hypoxia–reperfusion injury models. Journal of Pharmacological and Toxicological Methods 2013; 68(3): 349 doi: 10.1016/j.vascn.2013.03.002
|
17 |
Serdar Dogan, Mutay Aslan. Hepatic ischemia–reperfusion injury and therapeutic strategies to alleviate cellular damage. Hepatology Research 2011; 41(2): 103 doi: 10.1111/j.1872-034X.2010.00765.x
|
18 |
Chen Lu, Li Liu, Yuling Chen, Tuanzhu Ha, Jim Kelley, John Schweitzer, John H. Kalbfleisch, Race L. Kao, David L. Williams, Chuanfu Li. TLR2 Ligand Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of Phosphoinositide 3-Kinase/Akt Signaling. The Journal of Immunology 2011; 187(3): 1458 doi: 10.4049/jimmunol.1003428
|
19 |
Bjoern M. Thobe, Michael Frink, Frank Hildebrand, Martin G. Schwacha, William J. Hubbard, Mashkoor A. Choudhry, Irshad H. Chaudry. The role of MAPK in Kupffer cell toll‐like receptor (TLR) 2‐, TLR4‐, and TLR9‐mediated signaling following trauma‐hemorrhage. Journal of Cellular Physiology 2007; 210(3): 667 doi: 10.1002/jcp.20860
|
20 |
Yuanting Gu, Heshui Wu, Jianbo Xu, Lin Wang, Yuan Tian, Chunyou Wang. Expression of toll-like receptor 2/4 on alveolar macrophage in the model of total hepatic ischemia/reperfusion injury in mice. The Chinese-German Journal of Clinical Oncology 2006; 5(4): 298 doi: 10.1007/s10330-006-0498-6
|
21 |
Brigitte Vollmar, Michael D. Menger. The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair. Physiological Reviews 2009; 89(4): 1269 doi: 10.1152/physrev.00027.2008
|
22 |
Xiao-Jing Zhang, Peng Zhang, Hongliang Li. Interferon Regulatory Factor Signalings in Cardiometabolic Diseases. Hypertension 2015; 66(2): 222 doi: 10.1161/HYPERTENSIONAHA.115.04898
|
23 |
F. Arslan, B. Keogh, P. McGuirk, A. E. Parker. TLR2 and TLR4 in Ischemia Reperfusion Injury. Mediators of Inflammation 2010; 2010: 1 doi: 10.1155/2010/704202
|
24 |
Wei Ma, Zuo-Ren Wang, Lei Shi, Yue Yuan. Expression of macrophage inflammatory protein-1α in Kupffer cells following liver ischemia or reperfusion injury in rats. World Journal of Gastroenterology 2006; 12(24): 3854-3858 doi: 10.3748/wjg.v12.i24.3854
|
25 |
Hossein Ali Arab, Farhang Sasani, Mohammad Hossein Rafiee, Ahmad Fatemi, Abbas Javaheri. Histological and biochemical alterations in early-stage lobar ischemia-reperfusion in rat liver. World Journal of Gastroenterology 2009; 15(16): 1951-1957 doi: 10.3748/wjg.15.1951
|
26 |
Moustafa O. Aboelez, Hend A. A. Ezelarab, Ghallab Alotaibi, Deiaa E. Elsayed Abouzed. Inflammatory setting, therapeutic strategies targeting some pro-inflammatory cytokines and pathways in mitigating ischemia/reperfusion-induced hepatic injury: a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(9): 6299 doi: 10.1007/s00210-024-03074-y
|
27 |
Safak Kiziltas. Toll-like receptors in pathophysiology of liver diseases. World Journal of Hepatology 2016; 8(32): 1354-1369 doi: 10.4254/wjh.v8.i32.1354
|
28 |
Ioanna Vasileiou, Georgia Kostopanagiotou, Athanasios Katsargyris, Chris Klonaris, Despina Perrea, Stamatios Theocharis. Toll-like receptors: a novel target for therapeutic intervention in intestinal and hepatic ischemia–reperfusion injury?. Expert Opinion on Therapeutic Targets 2010; 14(8): 839 doi: 10.1517/14728222.2010.500286
|
29 |
Nari Yun, Jung-Woo Kang, Sun-Mee Lee. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. The Journal of Nutritional Biochemistry 2012; 23(10): 1249 doi: 10.1016/j.jnutbio.2011.06.018
|
30 |
Ana Rosa Rincón Sánchez, Ana Maria Rivas‐Estilla. Role of probiotics in hepatic ischemia‐reperfusion injury. Journal of Gastroenterology and Hepatology 2006; 21(4): 629 doi: 10.1111/j.1440-1746.2006.04334.x
|
31 |
Yu Guan, Weifeng Yao, Ke Yi, Chunxiong Zheng, Shixian Lv, Yu Tao, Ziqing Hei, Mingqiang Li. Nanotheranostics for the Management of Hepatic Ischemia‐Reperfusion Injury. Small 2021; 17(23) doi: 10.1002/smll.202007727
|
32 |
Alexander Georg Khandoga, Andrej Khandoga, Hans-Joachim Anders, Fritz Krombach. POSTISCHEMIC VASCULAR PERMEABILITY REQUIRES BOTH TLR-2 AND TLR-4, BUT ONLY TLR-2 MEDIATES THE TRANSENDOTHELIAL MIGRATION OF LEUKOCYTES. Shock 2009; 31(6): 593 doi: 10.1097/SHK.0b013e318193c859
|
33 |
Christopher Y Lu, John Hartono, Martin Senitko, Jianlin Chen. The inflammatory response to ischemic acute kidney injury: a result of the ‘right stuff’ in the ‘wrong place’?. Current Opinion in Nephrology and Hypertension 2007; 16(2): 83 doi: 10.1097/MNH.0b013e3280403c4e
|